Interventional Oncology is a growing field that focuses on the use of minimally invasive techniques to diagnose, treat, and monitor cancer. This type of therapy is increasingly being used to reduce the need for traditional open surgery, and to improve the quality of life of patients with cancer. It is a rapidly evolving field, and the market for products and services related to interventional oncology is expected to grow significantly in the coming years.
There are a number of different products and services available in the interventional oncology market, ranging from minimally invasive imaging technologies to drug-eluting stents and radiation therapy. Imaging technologies such as computed tomography (CT) and magnetic resonance imaging (MRI) are used to diagnose and monitor tumors, while drug-eluting stents and radiation therapy are used to treat cancer.
The global interventional oncology market is projected to reach USD 2.9 billion by 2026 from USD 1.9 billion in 2020 and is projected to grow at a compound annual growth rate (CAGR) of over 6.8% from 2020 to 2026. The growth of the market is largely driven by factors such as the increasing prevalence of cancer, the rise in demand for minimally invasive procedures, technological advancements, and the growing.
Download a PDF Copy: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=203687164
Interventional Oncology Market – Key Players:
prominent players in this market included Medtronic (Ireland), Boston Scientific (US), BD (US), Terumo (Japan), Merit Medical (US), Angiodynamics (US), JJ (US), Teleflex (US), Cook Medical (US), HealthTronics (US), MedWaves (US), Sanarus (US), IMBiotechnologies (Canada), Trod Medical (US), IceCure Medical (Israel), Mermaid Medicals (Denmark), Interface Biomaterials BV (Netherlands), Guerbet (France), ABK Biomedical (Canada), Shape Memory Medical (US), Endo Shape (US), Monteris Medical (US), Instylla (US), Trisalus Lifesciences (US), Profound Medical Corp (Canada), Sirtex (US), Accuray (US), Baylis Medical (Canada), and ALPINION MEDICAL SYSTEMS (South Korea), among others.
This research report categorizes the interventional oncology market based on product, procedure, cancer type, end user, and region.
By Product
- Embolization Devices
- Radioembolic Agents
- Non-Radio embolic Agents
- Microspheres
- Coated Beads
- Microparticles
- Ablation Devices
- Radiofrequency (RF) Ablation Devices
- Microwave Ablation Devices
- Cryoablation Devices
- Other Ablation Devices
- Support Devices
- Microcatheters
- Guidewires
By Procedure
- Thermal Tumor Ablation
- Non-Thermal Tumor Ablation
- Transcatheter Arterial Chemoembolization
- Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
- Transcatheter Arterial Embolization/Bland Embolization
By Cancer Type
- Liver Cancer
- Lung Cancer
- Bone Metastasis
- Kidney Cancer
- Breast Cancer
- Prostate Cancer
- Other Cancers
By End Users
- Hospitals
- Ambulatory Surgery Centers
- Research Academic Institutes
Asia Pacific likely to emerge as the fastest-growing interventional oncology market, globally
Emerging Asian countries, such as China, India, South Korea, Taiwan, and Singapore, offer high-growth market players opportunities. The Asia Pacific interventional oncology market is projected to grow the fastest from 2020 to 2026. Their lucrative growth potential is driven by factors such as supportive government policies for product manufacturing cancer therapies, the rapid expansion of healthcare infrastructure in key Asian countries, and robust cancer research infrastructure in Japan.
By Region
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- RoE
- Asia Pacific
- Japan
- China
- India
- RoAPAC
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
Interventional Oncology Market Recent Developments
- In 2021, Boston Scientific (US) launched Launched the TheraSphere Y-90 Glass Microspheres
- In 2018, Merit Medical Systems (US) launched the Preclude IDeal Hydrophilic Sheath Introducer in EMEA markets
- In 2018, IMBiotechnologies (US) launched ‘Ekobi 500 Embolization Microspheres’ with an enhanced feature of detectability using ultrasound technology.
- In 2018, Medical City and distributor Gulf Medical Company to install the first IMRIS Surgical Theatre in Saudi Arabia.
- In 2018, Medtronic (Ireland) launched its OptiSphere embolization spheres designed for hypervascular tumor embolization in the US
Related Report Study:
Interventional Radiology Products Market
interventional radiology imaging market
About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road, Suite 430, Northbrook, IL 60062
USA: 1-888-600-6441 | [email protected]
Content Source:
https://www.marketsandmarkets.com/PressReleases/interventional-oncology.asp
https://www.marketsandmarkets.com/ResearchInsight/interventional-oncology-market.asp
https://www.prnewswire.com/news-releases/interventional-oncology-market
https://www.pharmiweb.com/press-release/2022-11-08/interventional-oncology
